A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for Proteinuric Kidney Disease
Drug: MZE829
72 locations incl. Decatur
Sponsor: Maze Therapeutics
Sex: All·Age: 18 - 68
Code: NCT06830629·Phase 2·Recruiting
Michigan has 2,327 paid clinical trials enrolling now across cities including Ann Arbor, Detroit and Grand Rapids. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Michigan include University of Michigan Health and Henry Ford Health, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .